Fabio
71 lines
3.0 KiB
Markdown
71 lines
3.0 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Clinical Research Pharmacies and Clinical Trials - Permits and Ownership"
|
||
description: "Clinical Research Pharmacies and Clinical Trials - Permits and Ownership"
|
||
jurisdiction: "us/states/md"
|
||
legislature: "Maryland General Assembly"
|
||
session: "2026"
|
||
identifier: "SB 778"
|
||
citation: "Maryland SB 778 (2026)"
|
||
classification: ["bill"]
|
||
subjects: []
|
||
status: "enacted"
|
||
primary_sponsors: ["Feldman"]
|
||
version_count: 3
|
||
action_count: 13
|
||
vote_count: 2
|
||
first_action: "2026-02-06"
|
||
last_action: "2026-04-28"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/498ecf74-d8cc-4270-abfc-89c1610eec22"
|
||
source_url: "http://mgaleg.maryland.gov/mgawebsite/Legislation/Details/sb0778?ys=2026RS"
|
||
source_hash: "8cf325508ecdbe9edac924f7ec2711b1651a9ee5b2b4ac3c76dfbbb206244967"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-md"]
|
||
---
|
||
|
||
# Maryland SB 778 (2026) — Clinical Research Pharmacies and Clinical Trials - Permits and Ownership
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **Chapter - Clinical Research Pharmacies and Clinical Trials - Permits and Ownership** (committee substitute) — [source](http://mgaleg.maryland.gov/2026RS/Chapters_noln/CH_206_sb0778t.pdf)
|
||
2. **First - Clinical Research Pharmacies and Clinical Trials - Permits, Ownership, and Definition of Practice of Medicine** (committee substitute) — [source](http://mgaleg.maryland.gov/2026RS/bills/sb/sb0778f.pdf)
|
||
3. **Third - Clinical Research Pharmacies and Clinical Trials - Permits and Ownership** (committee substitute) — [source](http://mgaleg.maryland.gov/2026RS/bills/sb/sb0778t.pdf)
|
||
|
||
## Votes
|
||
|
||
- On Third Reading — **129–6** (pass) · lower
|
||
- On Third Reading — **42–0** (pass) · upper
|
||
|
||
## Sponsors
|
||
|
||
- Feldman — primary (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2026-02-06** First Reading Finance `referral-committee`
|
||
- **2026-02-12** Hearing 3/03 at 1:00 p.m.
|
||
- **2026-03-19** Favorable with Amendments Report by Finance `committee-passage-favorable`
|
||
- **2026-03-19** Favorable with Amendments { `committee-passage-favorable`
|
||
- **2026-03-19** Second Reading Passed with Amendments
|
||
- **2026-03-20** Third Reading Passed `passage`
|
||
- **2026-03-21** Referred Health `referral-committee`
|
||
- **2026-03-25** Hearing 4/02 at 1:00 p.m.
|
||
- **2026-04-11** Favorable Report by Health `committee-passage-favorable`
|
||
- **2026-04-11** Favorable Adopted Second Reading Passed `committee-passage-favorable`
|
||
- **2026-04-13** Third Reading Passed `passage`
|
||
- **2026-04-13** Returned Passed
|
||
- **2026-04-28** Approved by the Governor - Chapter 206 `executive-signature`
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/498ecf74-d8cc-4270-abfc-89c1610eec22`. Confidence: reported (aggregated from official Maryland legislature records).
|
||
|